Amphetamine/Dextroamphetamine

CHEMBL5095505 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A mixed amphetamine salt product combining multiple forms of amphetamine to treat ADHD and narcolepsy by boosting dopamine and norepinephrine signaling in the brain. The combination of salts aims to provide a more consistent therapeutic effect throughout the day.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(N)Cc1ccccc1.C[C@H](N)Cc1ccccc1.C[C@H](N)Cc1ccccc1

InChI

InChI=1S/3C9H13N/c3*1-8(10)7-9-5-3-2-4-6-9/h3*2-6,8H,7,10H2,1H3/t2*8-;/m00./s1

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A mixed amphetamine salt product combining multiple forms of amphetamine to treat ADHD and narcolepsy by boosting dopamine and norepinephrine signaling in the brain. The combination of salts aims to provide a more consistent therapeutic effect throughout the day.

Yes, Amphetamine/Dextroamphetamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5095505. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Procura informações acessíveis para o paciente?

Amphetamine/Dextroamphetamine no PillFYI

Estrutura

Dados Rápidos

Links Externos

ChEMBL CHEMBL5095505

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.